Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
In the latest session, Ocular Therapeutix Inc (NASDAQ: OCUL) closed at $7.06 down -5.23% from its previous closing price of $7.45. In other words, the price has decreased by -$5.23 from its previous closing price. On the day, 1.19 million shares were traded.
Ratios:
For a deeper understanding of Ocular Therapeutix Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.14 and its Current Ratio is at 10.22. In the meantime, Its Debt-to-Equity ratio is 0.29 whereas as Long-Term Debt/Eq ratio is at 0.28.
On March 18, 2025, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $17.
On March 11, 2025, Needham started tracking the stock assigning a Buy rating and target price of $15.Needham initiated its Buy rating on March 11, 2025, with a $15 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Feb 24 ’25 when Dugel Pravin sold 21,475 shares for $6.87 per share. The transaction valued at 147,533 led to the insider holds 3,520,318 shares of the business.
Heier Jeffrey S. sold 3,061 shares of OCUL for $21,029 on Feb 24 ’25. The Chief Scientific Officer now owns 265,998 shares after completing the transaction at $6.87 per share. On Feb 24 ’25, another insider, Kaiser Peter, who serves as the Chief Development Officer of the company, sold 3,009 shares for $6.87 each. As a result, the insider received 20,672 and left with 210,078 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 18.85 while its Price-to-Book (P/B) ratio in mrq is 4.23.
Stock Price History:
Over the past 52 weeks, OCUL has reached a high of $11.77, while it has fallen to a 52-week low of $4.79. The 50-Day Moving Average of the stock is -5.16%, while the 200-Day Moving Average is calculated to be -16.99%.
Shares Statistics:
A total of 159.26M shares are outstanding, with a floating share count of 134.14M. Insiders hold about 15.79% of the company’s shares, while institutions hold 72.87% stake in the company.
